Hey guys,
after reading about the good outcomes after Rituximab treatment, i started a Rituximab therapy myself. Sadly it did nothing for me and im now thinking about testing Cyclophosphamide. I saw the CycloME study and that the follow-up period is over.
"Status, CycloME part A
The treatment and follow-up phases were completed in August 2017."
They said they want to publish the result some day in 2018, but honestly, i dont want to wait that long anymore. I wrote Fluge an eMail some time ago, but sadly he didnt respond. Does anyone know anything about the cycloME study ? Do they maybe talk about some of the results like they did last year with Retuximab any time soon ?
Im asking myself, is there a good indication that Cyclophosphamide can help Rituximab non-responders ? ( They included 40 ppl about 20 of them who didnt benefit from Rituximab )
Also very interested in any news regarding Filgotinib. Seems very promising for other autoimmune diseases.
Any help is appreciated thanks
after reading about the good outcomes after Rituximab treatment, i started a Rituximab therapy myself. Sadly it did nothing for me and im now thinking about testing Cyclophosphamide. I saw the CycloME study and that the follow-up period is over.
"Status, CycloME part A
The treatment and follow-up phases were completed in August 2017."
They said they want to publish the result some day in 2018, but honestly, i dont want to wait that long anymore. I wrote Fluge an eMail some time ago, but sadly he didnt respond. Does anyone know anything about the cycloME study ? Do they maybe talk about some of the results like they did last year with Retuximab any time soon ?
Im asking myself, is there a good indication that Cyclophosphamide can help Rituximab non-responders ? ( They included 40 ppl about 20 of them who didnt benefit from Rituximab )
Also very interested in any news regarding Filgotinib. Seems very promising for other autoimmune diseases.
Any help is appreciated thanks